-
B.
Stamm
(2004)
Collaboration with other firms and customers: innovation’s secret weapon
Strategy & Leadership, 32
-
K.
Dittrich,
G.
Duysters
(2007)
Networking as a Means to Strategy Change: The Case of Open Innovation in Mobile Telephony
Journal of Product Innovation Management, 24
-
F.
Malerba,
L.
Orsenigo
(2002)
Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history‐friendly model
Industrial and Corporate Change, 11
-
H.
Glass,
L.
Poli
(2009)
“Pressure points” on pharmaceutical industry executives: what lies ahead?
International Journal of Pharmaceutical and Healthcare Marketing, 3
-
Dries
Faems
(2008)
Book review: Open Innovation: Researching a New Paradigm / by H. Chesbrough, W. Vanhaverbeke and J. West. - Oxford University Press. - ISBN 978-0-19929072-7
Creativity and Innovation Management, 17
-
P.
Herzog,
J.
Leker
(2010)
Open and closed innovation - different innovation cultures for different strategies
Int. J. Technol. Manag., 52
-
Linus
Dahlander,
D.
Gann
(2010)
How open is innovation
Research Policy, 39
-
A.
Gambardella
(1995)
Science and innovation: Science and innovation in pharmaceutical research
-
J.
DiMasi,
R.
Hansen,
H.
Grabowski
(2003)
The price of innovation: new estimates of drug development costs.
Journal of health economics, 22 2
-
10.4337/9781035303663.00009
-
K.
Dopfer,
J.
Foster,
J.
Potts
(2004)
Micro-meso-macro
Journal of Evolutionary Economics, 14
-
H.
Chesbrough
(2010)
Business Model Innovation: Opportunities and Barriers
Long Range Planning, 43
-
D.
Teece
(1993)
Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy
Research Policy, 15
-
T.
Hara
(2003)
Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development
-
B.
Munos
(2009)
Lessons from 60 years of pharmaceutical innovation
Nature Reviews Drug Discovery, 8
-
R.
Rothwell
(1992)
Successful industrial innovation: critical factors for the 1990s
R & D Management, 22
-
M.
Tushman,
K.
Lakhani,
Hila
Lifshitz-Assaf
(2012)
Open Innovation and Organization Design
Journal of Organization Design, 1
-
P.
Trott,
Dap
Hartmann
(2009)
WHY 'OPEN INNOVATION' IS OLD WINE IN NEW BOTTLES
International Journal of Innovation Management, 13
-
O.
Gassmann,
Gerrit
Reepmeyer
(2005)
Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers
Creativity and Innovation Management, 14
-
H.
Chesbrough,
R.
Rosenbloom
(2002)
The Role of the Business Model in Capturing Value from Innovation: Evidence from Xerox Corporation's Technology Spin-Off Companies
Industrial and Corporate Change, 11
-
M.
Bianchi,
A.
Cavaliere,
D.
Chiaroni,
F.
Frattini,
V.
Chiesa
(2011)
Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis
Technovation, 31
-
S.
Moon,
J.
Bermudez,
E.
Hoen
(2012)
Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
PLoS Medicine, 9
-
S.
Paul,
D.
Mytelka,
C.
Dunwiddie,
Charles
Persinger,
B.
Munos,
S.
Lindborg,
A.
Schacht
(2010)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Nature Reviews Drug Discovery, 9
-
I.
Khanna
(2012)
Drug discovery in pharmaceutical industry: productivity challenges and trends.
Drug discovery today, 17 19-20
-
H.
Chesbrough,
W.
Vanhaverbeke,
J.
West
(2008)
Open innovation : researching a new paradigm
-
P.
Bierly,
A.
Chakrabarti
(1996)
Generic knowledge strategies in the U.S. pharmaceutical industry
Southern Medical Journal, 17
-
Mapping the perception and reality of open innovation balance
-
M.
Dodgson,
D.
Gann,
A.
Salter
(2006)
The Role of Technology in the Shift Towards Open Innovation: The Case of Procter & Gamble
R & D Management, 36
-
D.
Chiaroni,
V.
Chiesa,
F.
Frattini
(2009)
Investigating the adoption of open innovation in the bio‐pharmaceutical industry: A framework and an empirical analysis
European Journal of Innovation Management, 12
-
V.
Chiesa,
G.
Toletti
(2004)
Network of Collaborations for Innovation: The Case of Biotechnology
Technology Analysis & Strategic Management, 16
-
Keld
Laursen,
A.
Salter
(2006)
Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms
Southern Medical Journal, 27
-
Sabine
Brunswicker,
W.
Vanhaverbeke
(2015)
Open Innovation in Small and Medium‐Sized Enterprises (SMEs): External Knowledge Sourcing Strategies and Internal Organizational Facilitators
Journal of Small Business Management, 53
-
A.
Spithoven,
B.
Clarysse,
Mirjam
Knockaert
(2010)
Building absorptive capacity to organise inbound open innovation in traditional industries
Technovation, 30
-
C.
Freeman
(1975)
Economics of Industrial Innovation
-
D.
Chiaroni,
V.
Chiesa,
F.
Frattini
(2011)
The Open Innovation Journey: How firms dynamically implement the emerging innovation management paradigm
Technovation, 31
-
Jackie
Hunter,
Susie
Stephens
(2010)
Is open innovation the way forward for big pharma?
Nature Reviews Drug Discovery, 9
-
Strength and Opportunity
(2014)
The landscape of the medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors in the UK
-
D.
Light,
J.
Lexchin
(2012)
Pharmaceutical research and development: what do we get for all that money?
BMJ : British Medical Journal, 345
-
D.
Teece
(2010)
Business Models, Business Strategy and Innovation
Long Range Planning, 43
-
K.
Samsom,
M.
Gurdon
(1993)
University scientists as entrepreneurs: a special case of technology transfer and high-tech venturing
Technovation, 13
-
M.
Saunders,
P.
Lewis,
A.
Thornhill
(2007)
Research Methods for Business Students (5th edn)
-
C.
Prahalad,
G.
Hamel
(1990)
The Core Competence of the Corporation
Harvard Business Review, 68
-
Q.
Chung,
Wenhong
Luo,
William
Wagner
(2006)
Strategic alliance of small firms in knowledge industries: A management consulting perspective
Bus. Process. Manag. J., 12
-
R.
Casadesus-Masanell,
J.
Ricart
(2010)
From Strategy to Business Models and onto Tactics
Long Range Planning, 43
-
Is the pharmaceutical industry open for innovation
Drug Discovery World
-
Martin
Srholec
(2011)
A Multilevel Analysis of Innovation in Developing Countries
Econometrics: Applied Econometrics & Modeling eJournal
-
E.
Huizingh
(2011)
Open innovation: State of the art and future perspectives
Technovation, 31
-
W.
Vanhaverbeke,
Myriam
Cloodt
(2006)
Open innovation in value networks
-
Open innovation in SMEs: from closed boundaries to networked paradigm
Information in Motion: The Journal Issues in Informing Science and Information Technology, 7
-
Realising the Value of Open Innovation
-
Ana
Burcharth,
M.
Knudsen,
Helle
Søndergaard
(2014)
Neither invented nor shared here: The impact and management of attitudes for the adoption of open innovation practices
Technovation, 34
-
H.
Chesbrough
(2003)
The Era of Open Innovation
MIT Sloan Management Review, 44
-
W.
Powell
(1998)
Learning from Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries
California Management Review, 40
-
C.
Verbano,
M.
Crema,
K.
Venturini
(2015)
The Identification and Characterization of Open Innovation Profiles in Italian Small and Medium‐sized Enterprises
Journal of Small Business Management, 53
-
M.
Lowman,
P.
Trott,
A.
Hoecht,
Zaki
Sellam
(2012)
Innovation risks of outsourcing in pharmaceutical new product development
Technovation, 32
-
Jong
Jpj,
W.
Vanhaverbeke,
Vrande
Vja,
Rochemont
Mh
(2009)
Open innovation in SMEs : trends, motives and management challenges
Steel and Composite Structures
-
Generic knowledge strategies in the US pharmaceutical industry
Strategic Management Journal, 17
-
J.
Niosi
(2003)
Alliances are not enough explaining rapid growth in biotechnology firms
Research Policy, 32
-
10.4337/9781035303663.00010
-
H.
Chesbrough
(2003)
Open Innovation: The New Imperative for Creating and Profiting from Technology
-
R.
Oakey
(2007)
Clustering and the R&D Management of High-Technology Small Firms: In Theory and Practice
ERN: Innovation (Topic)
-
Anahita
Baregheh,
J.
Rowley,
S.
Sambrook
(2009)
Towards a multidisciplinary definition of innovation
Management Decision, 47
-
V.
Omachonu
(2010)
Innovation in Healthcare Delivery Systems: A Conceptual Framework
The Innovation Journal, 15
-
Wesley
Cohen,
Daniel
Levinthal
(1990)
ABSORPTIVE CAPACITY: A NEW PERSPECTIVE ON LEARNING AND INNOVATION
Administrative Science Quarterly, 35
-
K.
Kaitin,
J.
DiMasi
(2011)
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009
Clinical Pharmacology & Therapeutics, 89
-
U.
Lichtenthaler
(2008)
Open Innovation in Practice: An Analysis of Strategic Approaches to Technology Transactions
IEEE Transactions on Engineering Management, 55
-
J.
West,
S.
Gallagher
(2006)
Challenges of Open Innovation: The Paradox of Firm Investment in Open-Source Software
Wiley-Blackwell: R&D Management
-
H.
Chesbrough
(2010)
The Future of Open Innovation
Research-Technology Management, 60
-
Erwin
Danneels
(2002)
The dynamics of product innovation and firm competences
Southern Medical Journal, 23
-
A.
Spithoven,
W.
Vanhaverbeke,
Nadine
Roijakkers
(2011)
Open innovation practices in SMEs and large enterprises
Small Business Economics, 41
-
W.
Comanor,
F.
Scherer
(2013)
Mergers and innovation in the pharmaceutical industry.
Journal of health economics, 32 1
-
R.
Oakey
(2013)
Open innovation and its relevance to industrial research and development: The case of high-technology small firms
International Small Business Journal, 31
-
R.
Ottewill,
P.
Jennings,
P.
Magirr
(2000)
Management competence development for professional service SMEs: the case of community pharmacy
Journal of Education and Training, 42
-
U.
Lichtenthaler
(2011)
‘Is open innovation a field of study or a communication barrier to theory development?’ A contribution to the current debate
Technovation, 31
-
H.
Chesbrough
(2007)
Why Companies Should Have Open Business Models
MIT Sloan Management Review, 48
-
A.
Arora,
A.
Gambardella
(1994)
Evaluating technological information and utilizing it: Scientific knowledge, technological capability, and external linkages in biotechnology
Journal of Economic Behavior and Organization, 24
-
C.
Gurau
(2004)
Positioning strategies in the value‐added chain of the biopharmaceutical sector: the case of UK SMEs
Journal of Consumer Marketing, 21
-
Mokter
Hossain
(2015)
A review of literature on open innovation in small and medium-sized enterprises
Journal of Global Entrepreneurship Research, 5
-
L.
Mortara,
T.
Minshall
(2011)
How do large multinational companies implement open innovation
Technovation, 31
-
Dusya
Vera,
M.
Crossan
(2004)
Strategic Leadership and Organizational Learning
Academy of Management Review, 29
-
J.
Alegre,
K.
Sengupta,
R.
Lapiedra
(2013)
Knowledge management and innovation performance in a high-tech SMEs industry
International Small Business Journal, 31
-
A.
Strauss
(1992)
Basics Of Qualitative Research
-
A.
Pullen,
P.
Weerd-Nederhof,
A.
Groen,
O.
Fisscher
(2012)
Open Innovation in Practice: Goal Complementarity and Closed NPD Networks to Explain Differences in Innovation Performance for SMEs in the Medical Devices Sector
Creativity and Innovation Management
-
Asher
Mullard
(2012)
Drug repurposing programmes get lift off
Nature Reviews Drug Discovery, 11
-
K.
Hung,
C.
Chou
(2013)
The impact of open innovation on firm performance: The moderating effects of internal R&D and environmental turbulence
Technovation, 33
-
Valérie
Sabatier,
V.
Mangematin,
Tristan
Rouselle
(2010)
Orchestrating networks in the biopharmaceutical industry: small hub firms can do it
Production Planning & Control, 21
-
J.
Drews
(2000)
Drug discovery: a historical perspective.
Science, 287 5460
-
D.
Hambrick
(1989)
Putting top managers back in the strategy picture
-
D.
Chiaroni,
V.
Chiesa,
F.
Frattini
(2008)
Patterns of collaboration along the biopharmaceutical innovation process
, 5
-
V.
Parida,
M.
Westerberg,
Johan
Frishammar
(2012)
Inbound Open Innovation Activities in High‐Tech SMEs: The Impact on Innovation Performance
Journal of Small Business Management, 50
-
Sungjoon
Lee,
Gwangman
Park,
B.
Yoon,
Jinwoo
Park
(2010)
Open innovation in SMEs—An intermediated network model
Research Policy, 39
-
Alexander
Schuhmacher,
P.
Germann,
H.
Trill,
O.
Gassmann
(2013)
Models for open innovation in the pharmaceutical industry.
Drug discovery today, 18 23-24
-
S.
Subramaniam
(2003)
Productivity and attrition: key challenges for biotech and pharma.
Drug discovery today, 8 12
-
D.
Light,
R.
Warburton
(2011)
Demythologizing the high costs of pharmaceutical research
BioSocieties, 6
-
Marcus
Keupp,
O.
Gassmann
(2009)
Determinants and Archetype Users of Open Innovation
New Institutional Economics
-
Pharmaceutical research and development: what do we get for all that money?
BMJ, 345
-
A multilevel analysis of innovation in developing countries
Industrial and Corporate Change, 20
-
W.
Powell,
K.
Koput,
Laurel
Smith‐Doerr
(1996)
Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology.
Administrative Science Quarterly, 41
-
B.
Quélin
(2000)
Core competencies, R&D management and partnerships
European Management Journal, 18
-
E.
Roberts
(1991)
Entrepreneurs In High Technology
-
John
LaMattina
(2011)
The impact of mergers on pharmaceutical R&D
Nature Reviews Drug Discovery, 10
-
Jill
Altshuler,
E.
Balogh,
A.
Barker,
S.
Eck,
S.
Friend,
G.
Ginsburg,
R.
Herbst,
S.
Nass,
C.
Streeter,
J.
Wagner
(2010)
Opening Up to Precompetitive Collaboration
Science Translational Medicine, 2
-
U.
Lichtenthaler,
H.
Ernst
(2009)
Opening Up the Innovation Process: The Role of Technology Aggressiveness
Entrepreneurship
-
T.
Mélèse,
Salima
Lin,
Julia
Chang,
N.
Cohen
(2009)
Open innovation networks between academia and industry: an imperative for breakthrough therapies
Nature Medicine, 15
-
J.
Attridge
(2007)
Innovation Models In The Biopharmaceutical Sector